Phase IIIb, Multicentre Study to Assess Safety & Immunogenicity of GSK Biologicals' Combined DTPa/Hib (Infanrix/Hib) Vaccine vs Separate Administration of DTPa (Infanrix) & Hib (Hiberix) Vaccines in Healthy Infants 3,4,&5 Months of Age as Compared With the Separate Administration of DTPa and Hib Vaccines at Different Injection Sites.
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2018
At a glance
- Drugs Hib-DTaP vaccine (Primary) ; DTaP vaccine; Hib vaccine conjugate
- Indications Diphtheria; Haemophilus infections; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 27 Oct 2007 Status changed from recruiting to completed.
- 18 Jan 2007 Status change
- 09 Jan 2007 New trial record.